STAT+: Vertex kidney disease drug scrutinized for infection risk
· statnews.com · popularity 33/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at statnews.com →
Summary
Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 5.